| 000 | 01365 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513233509.0 | ||
| 264 | 0 | _c20010913 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a1040-8428 | ||
| 024 | 7 |
_a10.1016/s1040-8428(00)00133-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKashmiri, S V | |
| 245 | 0 | 0 |
_aDevelopment of a minimally immunogenic variant of humanized anti-carcinoma monoclonal antibody CC49. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cApr 2001 |
||
| 300 |
_a3-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Heterophile _xgenetics |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _ximmunology |
| 650 | 0 | 4 |
_aComplementarity Determining Regions _xanalysis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aIwahashi, M | |
| 700 | 1 | _aTamura, M | |
| 700 | 1 | _aPadlan, E A | |
| 700 | 1 | _aMilenic, D E | |
| 700 | 1 | _aSchlom, J | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 38 _gno. 1 _gp. 3-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1040-8428(00)00133-5 _zAvailable from publisher's website |
| 999 |
_c11191780 _d11191780 |
||